{
  "id": "81c1d5c8326e630ec8f0f7bfe6dfbb6718388bda",
  "title": "Sumitomo Pharma shares plunge nearly 16% despite greenlight for Parkinson's treatment",
  "summary_full": "Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.",
  "summary_public": "Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.",
  "url": "https://www.cnbc.com/2026/02/20/sumitomo-pharma-shares-plunge-despite-greenlight-for-parkinsons-treatment.html",
  "published_at": "2026-02-20T07:43:50+00:00",
  "source": "International: Top News And Analysis",
  "language": "en",
  "countries_detected": [],
  "countries_scored": [],
  "sentiment_by_country": null,
  "sentiment_error": null,
  "llm_version": null,
  "llm_perspective": null,
  "llm_attempted_at": null,
  "processed_at": null
}